Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: Differential regulation by dexamethasone and LIF

Bone

Volumn 31, Issue 1, 2002, Pages 212-219

  Liu, F ^a   Aubin, J E ^b   Malaval, L ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone nodules; GP130; LIF; OSM; Osteoblast differentiation; Osteoprogenitors

Indexed keywords

CARDIOTROPHIN 1; CILIARY NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR RECEPTOR; CYTOKINE RECEPTOR; DEXAMETHASONE; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; ONCOSTATIN M; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CALVARIA; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; FETUS; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FETUS; GENE EXPRESSION REGULATION; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPHOKINES; MULTIGENE FAMILY; OSTEOGENESIS; RATS; RATS, WISTAR; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-6; RECEPTORS, OSM-LIF;

EID: 0036309608     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00806-2     Document Type: Article

References (37)

1. The osteoblast lineage
2. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation
3. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells
4. Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro
5. Physiological concentration of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro
6. Mineralized bone nodules formed from enzymatically released rat calvaria cell populations
7. Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells
8. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteogenic phenotype by dexamethasone
9. Genomic sequencing
10. The effects of leukemia inhibitory factor on bone in vivo
11. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
12. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
13. Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures
14. Cell sorting enriches osteogenic populations in rat bone marrow stromal cell cultures
15. Interleukin-11 inhibits bone formation in vitro
16. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice
17. Glucocorticoid-induced osteoporosis: Both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation
18. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor) - Regulation of its production and possible roles in bone metabolism
19. IL-6 is produced by osteoblasts and induces bone resorption
20. Biphasic effect of Oncostatin M on osteoprogenitor differentiation and bone formation in vitro
21. Simultaneous detection of multiple bone-related mRNA and protein expression during osteoblast differentiation: Polymerase chain reaction and immunocytochemical studies at the single cell level
22. Biphasic effects of leukemia inhibitory factor on osteoblastic differentiation
23. Leukemia inhibitory factor (LIF) inhibits osteogenic differentiation in rat calvaria cell cultures
24. LIF, but not IL6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: Modulation by dexamethasone
25. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro
26. Cellular expression of bone related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures
27. Developmental abnormalities in mice transgenic for bovine oncostatin M
28. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
29. Leukemia inhibitory factor and bone cell function
30. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor
31. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix
32. Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component
33. Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family
34. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype
35. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
36. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death
37. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders